Background -A new portable spirometer, the Spirophone, has been developed that records a subject's blow and can then transmit all the data by telephone to a receiving centre for analysis and comment. Tests ofthis device were undertaken to determine its accuracy and reliability. Methods -The performance of the Spirophone was tested using computer generated wave forms, by delivering blows from calibrated syringes at different flows, and by comparing subjects' blows with those recorded with a commercial spirometer.
Home monitoring of lung function is becoming increasingly important in the management of asthma, chronic obstructive lung disease,'-3 and after lung transplantation. The most widely used devices in patient self-monitoring of daily medication and in clinical drug efficacy studies have been peak flow meters, and portable spirometers have also been used to measure forced vital capacity (FVC), forced expiratory volume in one second (FEVy), and peak expiratory flow (PEF). A transtelephonic portable personal spirometer (Spirophone AG-SP) with a remote receiving centre (CG-80 10) has been developed (Card Guard, Rishon Le Zion, Israel) which can measure lung function indices at a patient's home and transmit the data to a remote receiving centre for analysis of both spirograms and flow-volume curves. We have evaluated the accuracy, reliability, and reproducibility of this system in the laboratory and in an operational setting.
Methods
The Spirophone comprises an unheated Fleisch pneumotachograph with differential pressure transducer, microprocessor, memory, and speaker which operates with a 9 volt battery and samples the flow signal at 400 Hz using a 12 bit A/D converter. The flow meter is 150 mm long and accepts standard 28 mm internal diameter mouthpieces. Ambient temperature is recorded to within 1°C during the blow as recommended by the American Thoracic Society,4 and its operational range is up to eight litres in volume, 141/s flow, and 30 second duration for recording vital capacity (VC) and up to 25 seconds for FVC. The following spirometric indices are calculated by the microprocessor of the Spirophone: VC, FVC, FEV, and FEV3, PEF, and the maximal expiratory flow when 75%, 50% and 25% of FVC remain to be expired (MEF75, MEF50, and MEF25). The FEV, and FEV3 are calculated using back extrapolation4 and are also expressed as a percentage of VC and FVC (FEV,/VC, FEVI/ FVC, etc). The Spirophone records one blow at a time and then modulates the data into tones for transmission by telephone to a receiving centre using acoustic coupling. The transmission of data takes 30 seconds which includes the application of a data verification algorithm.
The receiving centre requires a 486 personal computer with 4 Mb RAM, a receiving demodulator unit, and a printer. On receiving a call from a patient, an operator at the receiving centre instructs the patient to transmit the data by placing the phone handset on to the Spirophone's speaker. The receiving unit demodulates the data, performs a BTPS correction (see Appendix), and presents it on screen with the spirogram and flow-volume curve. If the blow is deemed acceptable according to ATS recommendations4 it is then stored in a database and the patient can then be instructed with respect to further blows or their clinical management. The system is only suitable for patients who have been assessed as able to perform the expiratory manoeuvres satisfactorily when unsupervised.
The Spirophone was compared with a commercial Fleisch pneumotachograph electronic spirometer (Fukuda Spiroanalyzer Model ST-250) with an identical operational range but whose heating element we disconnected during measurements with calibrated syringes. The electronic circuitry and microprocessor software of the Spirophone were tested with computer simulated "Gaussian" flow-time signals (symmetric signal around the mean) applied directly to the A/D converter. 5 The linearity of the Spirophone was tested by discharging through the Spirophone a computer driven volume-time ramp profile -that is, constant flow -at different flows using a three litre servocontrolled piston pump.6 One litre and three litre syringes were then discharged through the Spirophone and the commercial spirometer after each was calibrated for ambient temperature with no BTPS correction being applied. The syringes were fitted directly to the spirometers to minimise turbulence and resonance. 7 Tests with human subjects were conducted with the ambient temperature between 21°C and 23°C and barometric pressure at 750-755 mm Hg. One normal subject and two patients performed 10 repeated FVC manoeuvres separately through each spirometer. The Spirophone and commercial spirometer were then connected in series and 10 normal subjects performed FVC manoeuvres.59 Fifteen patients (nine women) aged 13-64 years with evidence of airflow limitation performed relaxed and forced VC manoeuvres separately with the Spirophone and commercial spirometer.9-12 Three acceptable blows were recorded and the best results were used for analysis. The Spirophone data were transmitted via a telephone in the same room.
Reliability and drift in calibration under typical home use were tested in nine Spirophones each calibrated with a one litre syringe and supplied with a new battery. Five patients each transmitted FVC tests daily from home for three months with the Spirophones being returned to the laboratory once a month for check testing. Four other Spirophones were used to transmit FVC manoeuvres by telephone from the laboratory and were check tested on alternate days for 30 days. The check testing in each case consisted of inspection for damage, correct operation, battery status, and assessment of calibration. Statistical analysis was by the paired Student's t test with a probability of 5% being taken as significant.
Results
When tested with constant flows up to 141/s from a computer driven syringe the linearity of the Spirophone was found to meet the ATS recommendation4 of +0-2 1/s or +5% of the reading, whichever is the greater, with the maximum absolute and percentage error being -0-098 1/s or 8 2%) at a flow of 1-2 1/s. Table  1 shows the results when the circuitry of the Spirophone was tested with simulated signals and the greatest error was less than 1 %. Figure  1 shows the volumes recorded with the Spirophone when tested with calibrating syringes discharged with varying flows. The maximum error was within +5% of the true volume. Table 2 shows the results for 10 rei manoeuvres for a healthy subjec patients with different spiron normalities. The reproducibility o1 phone was comparable with that fi mercial spirometer and there we nificant differences between the spir any of the lung function indices in; Figure 2 shows the comparison l results from 10 subjects recorde Spirophone and commercial spire nected in series. The FVC and within +5% in nine of the 10 su all the results being within + 7%.
The results for the 15 patients wit phone and the commercial spiro analysed according to the method presented in table 3 and show significantly lower readings with the Spirophone for relaxed VC and MEF25, with the differences not being related to the magnitude of the mean for the two spirometers. For all the other indices there was no significant difference and no trend in relation to mean value. When the Spirophones were tested for three months at home and in the 30 day laboratory based study all performed reliably without recording or transmission failure. A battery change was needed after 90-100 operations. The one litre volume calibrations were all accurate to within 5% throughout.
[ the Spiro-Discussion or the com-The Spirophone system was reliable and acere no sig-curate in both the recording and transmission of rometers for forced expiratory manoeuvres from a patient's any subject. home to a remote centre for analysis and combetween the ment. Such a system may have considerable d with the merit in the management of certain patients. meter con-In the last 10-15 years asthma prevalence and FEV, were mortality has been increasing in the USA"415 bjects, with and other countries. Many asthmatic subjects perform home monitoring of PEF using simple hthe Spiro-hand held meters, and this may lead to immeter were proved management of their asthma. ' how well a spirometer would perform with dynamic patient wave forms, and a sophisticated test using a computer-controlled mechanical pump with the 24 wave forms recommended by the ATS4 is necessary.624 In the present study a sophisticated computercontrolled mechanical pump was not available, and since dynamic wave form testing is essential, human data in a variety of test procedures were used. The Spirophone uses an unheated pneumotachograph which may lead to thermal and condensation errors.25 These effects can be minimised, however, by placing the pneumotachograph on a fan blowing ambient air26 between blows, and any such error would have affected both the spirometers used in our study and so could not have introduced a bias.
The Spirophone system has been shown to be reliable and accurate for forced expiratory manoeuvres and can be used as a diagnostic tool in clinical practice, in epidemiological studies, and in clinical drug efficacy studies. It may also overcome some of the limitations of the present home monitoring devices by providing important additional indices from the forced expiratory manoeuvre, by displaying spirograms and flow-volume curves to a technician or physician for analysis, and by allowing quality control over the blows recorded. However, since the blows are performed without visual supervision, the system is suitable only for patients who are able to perform the forced expiratory manoeuvre by themselves and can respond to advice given over the telephone.
